DYN logo

Dyne Therapeutics (DYN) Selling, general & administrative expenses

annual SGA:

$62.48M+$31.08M(+98.98%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual SGA is $62.48 million, with the most recent change of +$31.08 million (+98.98%) on December 31, 2024.
  • During the last 3 years, DYN annual SGA has risen by +$33.76 million (+117.57%).
  • DYN annual SGA is now at all-time high.

Performance

DYN SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNincome statement metrics

quarterly SGA:

$15.93M+$622.00K(+4.06%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly SGA is $15.93 million, with the most recent change of +$622.00 thousand (+4.06%) on March 31, 2025.
  • Over the past year, DYN quarterly SGA has dropped by -$8.69 million (-35.31%).
  • DYN quarterly SGA is now -35.31% below its all-time high of $24.62 million, reached on March 31, 2024.

Performance

DYN quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNincome statement metrics

TTM SGA:

-$3.64B-$367.13M(-11.22%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN TTM SGA is -$3.64 billion, with the most recent change of -$367.13 million (-11.22%) on March 31, 2025.
  • Over the past year, DYN TTM SGA has dropped by -$3.69 billion (-7666.78%).
  • DYN TTM SGA is now -18328.36% below its all-time high of -$19.75 million.

Performance

DYN TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

DYN Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+99.0%-35.3%-7666.8%
3 y3 years+117.6%+111.0%-10000.0%
5 y5 years+2142.6%+802.8%-10000.0%

DYN Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+121.5%-35.3%+161.4%-353.0%at low
5 y5-yearat high+2142.6%-35.3%+1087.5%-6356.5%at low
alltimeall timeat high>+9999.0%-35.3%+2361.4%<-9999.0%at low

DYN Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$15.93M(+4.1%)
$53.79M(-13.9%)
Dec 2024
$62.48M(+99.0%)
$15.30M(+19.0%)
$62.48M(+11.5%)
Sep 2024
-
$12.86M(+32.6%)
$56.02M(+11.6%)
Jun 2024
-
$9.70M(-60.6%)
$50.18M(+4.4%)
Mar 2024
-
$24.62M(+178.4%)
$48.09M(+53.2%)
Dec 2023
$31.40M(+11.3%)
$8.84M(+25.9%)
$31.40M(+6.4%)
Sep 2023
-
$7.02M(-7.7%)
$29.51M(-2.0%)
Jun 2023
-
$7.61M(-4.1%)
$30.10M(+5.3%)
Mar 2023
-
$7.93M(+14.0%)
$28.58M(+1.4%)
Dec 2022
$28.20M
$6.96M(-8.6%)
$28.20M(-8.7%)
Sep 2022
-
$7.61M(+24.9%)
$30.91M(+4.6%)
Jun 2022
-
$6.09M(-19.3%)
$29.55M(-0.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
$7.55M(-21.9%)
$29.75M(+3.6%)
Dec 2021
$28.72M(+113.6%)
$9.66M(+54.4%)
$28.72M(+12.4%)
Sep 2021
-
$6.26M(-0.6%)
$25.56M(+10.4%)
Jun 2021
-
$6.29M(-3.3%)
$23.14M(+27.2%)
Mar 2021
-
$6.51M(+0.1%)
$18.19M(+35.3%)
Dec 2020
$13.45M(+382.7%)
$6.50M(+69.3%)
$13.45M(+64.9%)
Sep 2020
-
$3.84M(+186.4%)
$8.16M(+64.4%)
Jun 2020
-
$1.34M(-24.0%)
$4.96M(+37.0%)
Mar 2020
-
$1.76M(+45.7%)
$3.62M(+94.9%)
Dec 2019
$2.79M(+438.9%)
$1.21M(+87.2%)
$1.86M(+187.2%)
Sep 2019
-
$647.00K
$647.00K
Dec 2018
$517.00K
-
-

FAQ

  • What is Dyne Therapeutics annual SGA?
  • What is the all time high annual SGA for Dyne Therapeutics?
  • What is Dyne Therapeutics annual SGA year-on-year change?
  • What is Dyne Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly SGA year-on-year change?
  • What is Dyne Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Dyne Therapeutics?
  • What is Dyne Therapeutics TTM SGA year-on-year change?

What is Dyne Therapeutics annual SGA?

The current annual SGA of DYN is $62.48M

What is the all time high annual SGA for Dyne Therapeutics?

Dyne Therapeutics all-time high annual SGA is $62.48M

What is Dyne Therapeutics annual SGA year-on-year change?

Over the past year, DYN annual SGA has changed by +$31.08M (+98.98%)

What is Dyne Therapeutics quarterly SGA?

The current quarterly SGA of DYN is $15.93M

What is the all time high quarterly SGA for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly SGA is $24.62M

What is Dyne Therapeutics quarterly SGA year-on-year change?

Over the past year, DYN quarterly SGA has changed by -$8.69M (-35.31%)

What is Dyne Therapeutics TTM SGA?

The current TTM SGA of DYN is -$3.64B

What is the all time high TTM SGA for Dyne Therapeutics?

Dyne Therapeutics all-time high TTM SGA is -$19.75M

What is Dyne Therapeutics TTM SGA year-on-year change?

Over the past year, DYN TTM SGA has changed by -$3.69B (-7666.78%)
On this page